Top-News

10x Genomics Aktie News

Aktie
WKN:  A2PPQJ ISIN:  US88025U1097 US-Symbol:  TXG Branche:  Gesundheitswesen: Anbieter u. Dienstleister Land:  USA
17,48 $
-0,67 $
-3,69%
15,013 € 19:56:44 Uhr
Depot/Watchlist
Marktkapitalisierung *
1,46 Mrd. €
Streubesitz
-
KGV
-9,57
Index-Zuordnung
-

10x Genomics News

18.11.25 - PR Newswire
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
New ASTRA Consortium Unites Asia-​Pacific Scientists to Build Pan-​Cancer Spatial Atlas Powered by 10x Genomics' Xenium PR Newswire
11.11.25 - PR Newswire
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 PR Newswire
06.11.25 - PR Newswire
10x Genomics Reports Third Quarter 2025 Financial Results
10x Genomics Reports Third Quarter 2025 Financial Results PR Newswire
29.10.25 - PR Newswire
Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners
Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners PR Newswire
29.10.25 - PR Newswire
Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners
Soaring Prices and Relentless Buying Create Perfect Storm for Gold Miners PR Newswire
29.10.25 - PR Newswire
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research PR Newswire
20.10.25 - PR Newswire
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences PR Newswire
19.10.25 - Maximilian Berger
Sonntag: 10X GENOMICS INC – Jetzt darf nichts verpasst werden!
Die Aktie von 10X Genomics (WKN A2PPQJ) zeigt sich stabil. Am Sonntag lohnt ein Blick auf Trends und Chancen rund um die Genomik-​Innovation.
09.10.25 - PR Newswire
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 PR Newswire
09.09.25 - PR Newswire
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics PR Newswire
27.08.25 - PR Newswire
10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference PR Newswire
19.08.25 - PR Newswire
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis PR Newswire
07.08.25 - PR Newswire
10x Genomics Reports Second Quarter 2025 Financial Results
10x Genomics Reports Second Quarter 2025 Financial Results PR Newswire
07.08.25 - PR Newswire
10x Genomics to Acquire Scale Biosciences
10x Genomics to Acquire Scale Biosciences PR Newswire
17.07.25 - PR Newswire
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery PR Newswire
10.07.25 - PR Newswire
10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 PR Newswire
14.05.25 - PR Newswire
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker PR Newswire
08.05.25 - PR Newswire
10x Genomics Reports First Quarter 2025 Financial Results
10x Genomics Reports First Quarter 2025 Financial Results PR Newswire
30.04.25 - PR Newswire
10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference
10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference PR Newswire
30.04.25 - PR Newswire
New Discoveries, Rising Prices, and Critical Metals Create Perfect Storm for Gold Explorers
New Discoveries, Rising Prices, and Critical Metals Create Perfect Storm for Gold Explorers PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +0,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »